Pathology of endometrial carcinoma

[1]  E. Oliva,et al.  Precursors and pathogenesis of ovarian carcinoma , 2013, Pathology.

[2]  M. Al-Hussaini,et al.  Undifferentiated endometrial carcinoma: a diagnosis frequently overlooked. , 2013, Archives of pathology & laboratory medicine.

[3]  E. Oliva,et al.  Clinical and Pathologic Characteristics of Serous Carcinoma Confined to the Endometrium: A Multi-institutional Study , 2013, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[4]  D. Klimstra,et al.  Lynch syndrome-associated neoplasms: a discussion on histopathology and immunohistochemistry , 2013, Familial Cancer.

[5]  I. Sohn,et al.  Poor prognosis of uterine serous carcinoma compared with grade 3 endometrioid carcinoma in early stage patients , 2013, Virchows Archiv.

[6]  S. Hori,et al.  Endometrial intraepithelial carcinoma in association with polyp: review of eight cases , 2013, Diagnostic Pathology.

[7]  J. Hecht,et al.  Morphologic and other clinicopathologic features of endometrial clear cell carcinoma: a comprehensive analysis of 50 rigorously classified cases. , 2013, American journal of cancer research.

[8]  O. Fadare,et al.  Diagnostic Utility of Hepatocyte Nuclear Factor 1-Beta Immunoreactivity in Endometrial Carcinomas: Lack of Specificity For Endometrial Clear Cell Carcinoma , 2012, Applied immunohistochemistry & molecular morphology : AIMM.

[9]  L. Massuger,et al.  Pure Compared With Mixed Serous Endometrial Carcinoma: Two Different Entities? , 2012, Obstetrics and gynecology.

[10]  K. Williamson,et al.  Clinical Outcome of Atypical Endometrial Hyperplasia Diagnosed on an Endometrial Biopsy: Institutional Experience and Review of Literature , 2012, The American journal of surgical pathology.

[11]  Jene Choi,et al.  Papillary mucinous metaplasia of the endometrium as a possible precursor of endometrial mucinous adenocarcinoma , 2012, Modern Pathology.

[12]  A. Usubutun,et al.  Reproducibility of endometrial intraepithelial neoplasia diagnosis is good, but influenced by the diagnostic style of pathologists , 2012, Modern Pathology.

[13]  W. McCluggage,et al.  Papillary Syncytial Metaplasia Associated With Endometrial Breakdown Exhibits an Immunophenotype That Overlaps With Uterine Serous Carcinoma , 2012, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[14]  E. Oliva,et al.  Molecular Profile of Grade 3 Endometrioid Endometrial Carcinoma: Is it a Type I or Type II Endometrial Carcinoma? , 2012, The American journal of surgical pathology.

[15]  John V. Brown,et al.  Primary Small Cell Neuroendocrine Carcinoma of the Endometrium , 2012, Case Reports in Oncology.

[16]  Takafumi Nakamura,et al.  A case of serous endometrial intraepithelial carcinoma with p53 positivity for six years , 2012, The journal of obstetrics and gynaecology research.

[17]  M. Elshaikh,et al.  Mucinous Adenocarcinoma of the Endometrium: Case Series and Review of the Literature , 2012, International Journal of Gynecologic Cancer.

[18]  G. Mills,et al.  Clinical Assessment of PTEN Loss in Endometrial Carcinoma: Immunohistochemistry Out-Performs Gene Sequencing , 2011, Modern Pathology.

[19]  G. Schaller,et al.  Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer-a clinical and pathological evaluation. , 2012, Gynecologic oncology.

[20]  E. Oliva,et al.  Endometrial Carcinomas: A Review Emphasizing Overlapping and Distinctive Morphological and Immunohistochemical Features , 2011, Advances in anatomic pathology.

[21]  D. Cramer,et al.  Endometrial Intraepithelial Neoplasia Clinical Correlates and Outcomes , 2011, Obstetrics and gynecology.

[22]  T. Longacre,et al.  Low-grade Mucinous Adenocarcinoma of the Uterine Corpus: A Rare and Deceptively Bland Form of Endometrial Carcinoma , 2011, The American journal of surgical pathology.

[23]  A. Giatromanolaki,et al.  The pathogenesis of endometrial carcinomas at menopause: facts and figures , 2011, Journal of Clinical Pathology.

[24]  E. Oliva,et al.  Nonendometrioid endometrial carcinomas. , 2010, Seminars in diagnostic pathology.

[25]  G. Mutter,et al.  Endometrial intraepithelial neoplasia. , 2010, Seminars in diagnostic pathology.

[26]  R. Soslow.  Endometrial carcinomas with ambiguous features. , 2010, Seminars in diagnostic pathology.

[27]  A. Beck,et al.  A Panel of 3 Markers Including p16, ProExC, or HPV ISH is Optimal for Distinguishing Between Primary Endometrial and Endocervical Adenocarcinomas , 2010, The American journal of surgical pathology.

[28]  A. Gadducci,et al.  Clear cell carcinoma of the endometrium: a biological and clinical enigma. , 2010, Anticancer research.

[29]  L. Tafe,et al.  Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms , 2010, Modern Pathology.

[30]  W. McCluggage,et al.  WT1, p53 and hormone receptor expression in uterine serous carcinoma , 2009, Histopathology.

[31]  M. Nucci,et al.  Coexisting Intraepithelial Serous Carcinomas of the Endometrium and Fallopian Tube: Frequency and Potential Significance , 2009, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[32]  G. Nuovo,et al.  Immunohistochemical Overexpression of p16 and p53 in Uterine Serous Carcinoma and Ovarian High-grade Serous Carcinoma , 2007, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[33]  H. Tsuda,et al.  Immunohistochemical detection of hepatocyte nuclear factor 1beta in ovarian and endometrial clear-cell adenocarcinomas and nonneoplastic endometrium. , 2007, Human pathology.

[34]  E. Ohno,et al.  Immunohistochemical expression of PTEN and beta-catenin for endometrial intraepithelial neoplasia in Japanese women. , 2007, Annals of diagnostic pathology.

[35]  N. Karahan,et al.  Immunohistochemical expression of PTEN in normal, hyperplastic and malignant endometrium and its correlation with hormone receptors, bcl-2, bax, and apoptotic index. , 2007, Pathology, research and practice.

[36]  O. Fadare,et al.  Precursors of Endometrial Clear Cell Carcinoma , 2006, The American journal of surgical pathology.

[37]  P. V. van Diest,et al.  The molecular genetics and morphometry‐based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system , 2005, Cancer.

[38]  M. Mazur.  Endometrial hyperplasia/adenocarcinoma. a conventional approach. , 2005, Annals of diagnostic pathology.

[39]  S. Lax.  Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification , 2004, Virchows Archiv.

[40]  N. Yaegashi,et al.  Small cell carcinoma of the endometrium: report of three cases and literature review , 2003, International Journal of Gynecologic Cancer.

[41]  S. Murata,et al.  Wilms Tumor Gene Immunoreactivity in Primary Serous Carcinomas of the Fallopian Tube, Ovary, Endometrium, and Peritoneum , 2003, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[42]  A. Giatromanolaki,et al.  Prognostic aspects on endometrial hyperplasia and neoplasia , 2001, Virchows Archiv.

[43]  S. Silverberg.  Problems in the Differential Diagnosis of Endometrial Hyperplasia and Carcinoma , 2000, Modern Pathology.

[44]  M. Sherman.  Theories of Endometrial Carcinogenesis: A Multidisciplinary Approach , 2000, Modern Pathology.